Zbornik Radova Pravnog Fakulteta u Splitu : Impact Factor & More
eISSN: 1847-0459pISSN: 0584-9063
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Zbornik Radova Pravnog Fakulteta u Splitu Journal Specifications
Indexed in the following public directories
DOAJ
| Overview | |
| Publisher | Pravni fakultet Sveučilišta u Splitu |
| Language | Serbian,English,Croatian |
| Publication Time | 10 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | Serbian,English,Croatian |
| Society/Institute/Sponsor | Pravni fakultet Sveučilišta u Splitu |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 10 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Zbornik Radova Pravnog Fakulteta u Splitu ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Zbornik Radova Pravnog Fakulteta u Splitu
CDK6 inactivation counteracts CALR\u2010mutant\u2010induced MPN evolution and sensitizes MPN stem cells to interferon\u2010\u03b1 treatment
- 12 May 2026
- HemaSphere
The rearrangement partner and the presence of MYC mutations determine the outcome of patients with MYC and BCL6 rearrangements
- 12 May 2026
- HemaSphere
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.
- 1 May 2026
- HemaSphere
Factors associated with response to rituximab in patients with immune thrombocytopenia.
- 1 May 2026
- HemaSphere
Fitusiran treatment modulates the ratio between alpha- and beta-antithrombin isoforms.
- 1 May 2026
- HemaSphere
A single JAK2-V617F hematopoietic stem cell can initiate myeloproliferative neoplasm when transplanted into non-conditioned recipient mice.
- 1 May 2026
- HemaSphere
CDK6 inactivation counteracts CALR\u2010mutant\u2010induced MPN evolution and sensitizes MPN stem cells to interferon\u2010\u03b1 treatment
- 12 May 2026
- HemaSphere
The rearrangement partner and the presence of MYC mutations determine the outcome of patients with MYC and BCL6 rearrangements
- 12 May 2026
- HemaSphere
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.
- 1 May 2026
- HemaSphere
Factors associated with response to rituximab in patients with immune thrombocytopenia.
- 1 May 2026
- HemaSphere
Fitusiran treatment modulates the ratio between alpha- and beta-antithrombin isoforms.
- 1 May 2026
- HemaSphere
A single JAK2-V617F hematopoietic stem cell can initiate myeloproliferative neoplasm when transplanted into non-conditioned recipient mice.
- 1 May 2026
- HemaSphere
FAQs on Zbornik Radova Pravnog Fakulteta u Splitu
How many articles did Zbornik Radova Pravnog Fakulteta u Splitu publish last year? 
What is the eISSN & pISSN for Zbornik Radova Pravnog Fakulteta u Splitu?
Who is the publisher of Zbornik Radova Pravnog Fakulteta u Splitu?
